FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face
By Benjamin Y. Fong, Honors Faculty Fellow, Associate Teaching Professor, and Associate Director of the Center for Work & Democracy, Arizona State University
The FDA’s decision shines a light on some of the unique obstacles that psychedelic drugs may face on the path to approval.
Read complete article
© The Conversation
-
Monday, August 12, 2024